January 22, 2018 / 11:47 AM / 3 months ago

BRIEF-Chromadex - Patent Trial And Appeal Board Of U.S. Patent And Trademark Office Denied Elysium Health's Request To Invalidate U.S. Patent

Jan 22 (Reuters) - Chromadex Corp:

* CHROMADEX - PATENT TRIAL AND APPEAL BOARD OF U.S. PATENT AND TRADEMARK OFFICE DENIED ELYSIUM HEALTH INC.’S REQUEST TO INVALIDATE U.S. PATENT

* CHROMADEX - U.S. PATENT COVERING COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE, WHICH CHROMADEX CURRENTLY LICENSES FROM TRUSTEES OF DARTMOUTH COLLEGE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below